The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis

The Association of CYP17A1, CYP19A1, and SHBG Gene Polymorphisms in Polycystic Ovary Syndrome Susceptibility: A Systematic Review and Meta-Analysis

Objective: To elucidate the relationship between CYP17A1/CYP19A1/SHBG gene polymorphisms and PCOS susceptibility.Methods: We searched multiple databases from inception to December 2020 and meta analysis was conducted to elucidate the relationship between gene polymorphisms and PCOS risk.Results: 26...

Full description

Bibliographic Details
Main Authors:	Chuan Xing, Han Zhao, Jiaqi Zhang, Bing He
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-05-01
Series:	Frontiers in Physiology
Subjects:	polycystic ovary syndrome single nucleotide polymorphism CYP19 CYP17 sex hormone binding globulin
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2022.741285/full

Similar Items

Genetic Variants of CYP11B2 and CYP1A1 Among the North-Indian Punjabi Females with Polycystic Ovary Syndrome
by: Ratneev Kaur, et al.
Published: (2022-12-01)

Plymorphism of CYP17 for Polycystic Ovarian Syndrome in Women of Salah Al-Din Provence/ Iraq
by: Hadeel Abdulhadi Omear, et al.
Published: (2014-01-01)

Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population
by: Jun Hyun Han, et al.
Published: (2015-04-01)

Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk
by: Piera Rizzolo, et al.
Published: (2019-08-01)

The relationship between the CYP19 alleles rs727479A/C, rs700518A/G, and rs700519C/T and pregnancy outcome after assisted reproductive technology in patients with polycystic ovary syndrome in a Chinese population: A population-based study
by: Qian Dou, et al.
Published: (2017-11-01)

Molecular study of CYP21 gene polymorphism rs13405728 and CYP11A1 gene polymorphism rs4077582 in polycystic ovarian syndrome patients
by: Nawal Sajid, et al.
Published: (2024-09-01)

Exploration of CYP21A2 and CYP17A1 polymorphisms and preeclampsia risk among Chinese Han population: a large-scale case-control study based on 5021 subjects
by: Bo Hou, et al.
Published: (2020-09-01)

Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome
by: Xiaofeng Guo, et al.
Published: (2024-06-01)

The Effect of Flavonoid Aglycones on the CYP1A2, CYP2A6, CYP2C8 and CYP2D6 Enzymes Activity
by: Mirza Bojić, et al.
Published: (2019-09-01)

The genetic profiles of CYP1A1, CYP1A2 and CYP2E1 enzymes as susceptibility factor in xenobiotic toxicity in Turkish population
by: Merve Arici, et al.
Published: (2017-02-01)

New biomarkers for diagnosis of polycystic ovary syndrome
by: Farid I. Hassan, et al.
Published: (2023-04-01)

Association of CYP19A1 and CYP1A2 genetic polymorphisms with type 2 diabetes mellitus risk in the Chinese Han population
by: Yafeng Yang, et al.
Published: (2020-08-01)

Delineating the role of single-nucleotide polymorphism of CYP19 gene on aromatase activity in South Indian women with polycystic ovary syndrome
by: Pravesh Hegde, et al.
Published: (2023-08-01)

THE ROLE OF CYP17A1 IN ADENOCARCINOMA OF THE PROSTATE AT SARDJITO GENERAL HOSPITAL
by: Dwi Prayogo, et al.
Published: (2020-01-01)

CYP1A1 and CYP2E1 polymorphism frequencies in a large Brazilian population
by: Renata dos Santos Coura, et al.
Published: (2007-01-01)

Effect of the Most Relevant CYP3A4 and CYP3A5 Polymorphisms on the Pharmacokinetic Parameters of 10 CYP3A Substrates
by: Miriam Saiz-Rodríguez, et al.
Published: (2020-04-01)

The influence of CYP1A1 and CYP1A2 polymorphisms on stroke risk in the Chinese population
by: Yan Mao, et al.
Published: (2020-10-01)

The Expression of Genes <i>CYP1A1</i>, <i>CYP1B1</i>, and <i>CYP2J3</i> in Distinct Regions of the Heart and Its Possible Contribution to the Development of Hypertension
by: Maria L. Perepechaeva, et al.
Published: (2024-10-01)

Mutated CYP17A1 promotes atherosclerosis and early-onset coronary artery disease
by: Ting-Ting Wu, et al.
Published: (2023-06-01)

Obesity is associated with SHBG levels rather than blood lipid profiles in PCOS patients with insulin resistance
by: Haolin Zhang, et al.
Published: (2024-11-01)

The Role of CYP3A in Health and Disease
by: Lyubov S. Klyushova, et al.
Published: (2022-10-01)

Integrated transcriptomic analysis on chicken ovary reveals CYP21A1 affects follicle granulosa cell development and steroid hormone synthesis
by: Zhangjing You, et al.
Published: (2024-05-01)

Effect of Differences in the Microbiome of <i>Cyp17a1</i>-Deficient Mice on Atherosclerotic Background
by: Axel Künstner, et al.
Published: (2021-05-01)

Halloween genes AhCYP307A2 and AhCYP314A1 modulate last instar larva–pupa–adult transition, ovarian development and oogenesis in Agasicles hygrophila (Coleoptera: Chrysomelidae)
by: Ji-su JIN, et al.
Published: (2023-03-01)

Atypical presentation in patients with 17 α-hydroxylase deficiency caused by a deletion in the CYP17A1 gene: short stature
by: Semih Bolu, et al.
Published: (2020-10-01)

Expression of vitamin D receptor, CYP24A1, and CYP27B1 in normal and inflamed canine pancreases
by: Dohee Lee, et al.
Published: (2023-09-01)

CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro
by: Rossini A., et al.
Published: (2006-01-01)

Efficacy and safety of antipsychotics in adolescents with an acute psychotic episode in relation to the activity of CYP3A and CYP2D6 isoenzymes
by: D. V. Ivashchenko, et al.
Published: (2020-12-01)

Characterization of the Interrenal Gland and Sexual Traits Development in cyp17a2-Deficient Zebrafish
by: Shengchi Shi, et al.
Published: (2022-06-01)

MOLECULAR-GENETIC FEATURES WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS)
by: Анжелика Юрьевна Беглова, et al.
Published: (2019-10-01)

Association of CYP3A4*1B, CYP3A4*22 and CYP3A5*3 polymorphisms carriage with efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia
by: Sh. P. Abdullaev, et al.
Published: (2024-05-01)

Comparisons of Prostate Cancer Inhibitors Abiraterone and TOK-001 Binding with CYP17A1 through Molecular Dynamics
by: Fei Xiao, et al.
Published: (2015-01-01)

Analysis of CYP3A4*1B and CYP3A5*3 polymorphisms in population of Bosnia and Herzegovina
by: Sabina Semiz, et al.
Published: (2011-02-01)

Downregulation of CYP17A1 by 20-hydroxyecdysone: plasma progesterone and its vasodilatory properties
by: Maneera Y Aljaber, et al.
Published: (2022-07-01)

Exploring the Chemical Space of CYP17A1 Inhibitors Using Cheminformatics and Machine Learning
by: Tianshi Yu, et al.
Published: (2023-02-01)

Synthesis and Structure–Activity Relationships of Novel Non-Steroidal CYP17A1 Inhibitors as Potential Prostate Cancer Agents
by: Tomasz M. Wróbel, et al.
Published: (2022-01-01)

DNA Methylation in the CYP3A Distal Regulatory Region (DRR) Is Associated with the Expression of CYP3A5 and CYP3A7 in Human Liver Samples
by: Joseph M. Collins, et al.
Published: (2024-11-01)

Polycystic Ovary Syndrome Phenotype D Versus Functional Hypothalamic Amenorrhea With Polycystic Ovarian Morphology: A Retrospective Study About a Frequent Differential Diagnosis
by: Klara Beitl, et al.
Published: (2022-06-01)

Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus
by: Sabina Semiz, et al.
Published: (2010-11-01)

Vitamin D status, vitamin D receptor, CYP2R1, and CYP24A1 profiles in children
by: Anggraini Iriani, et al.
Published: (2024-06-01)